Literature DB >> 341949

Mianserin in the treatment of depressive illness and anxiety states in general practice.

J E Murphy.   

Abstract

1. In an initial study in general practice, mianserin was shown to be of similar antidepressant efficacy to imipramine. 2. A subsequent placebo-controlled study confirmed that mianserin is an effective as imipramine, and also demonstrated that both mianserin and imipramine are superior to placebo in the treatment of depression in general practice. 3. In a third trial, mianserin was found to be as effective as diazepam in the treatment of anxiety states in general practice. 4. The overall incidence of side-effects in this series of studies, either with mianserin or with the comparison drugs, was very low.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 341949      PMCID: PMC1429194     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

2.  Three double-blind comparative trials of mianserine (ORG GB 94) and amitriptyline in the treatment of depressive illness.

Authors:  M O Jaskari; U G Ahfors; L Ginman; K Lydekcne; P Tienari
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1977-03

3.  Differential drug effects in neurotic depression.

Authors:  K Rickels; P Hesbacher; R W Downing
Journal:  Dis Nerv Syst       Date:  1970-07

4.  Studies in the classification of affective disorders. The relationship between anxiety states and depressive illnesses. I.

Authors:  M Roth; C Gurney; R F Garside; T A Kerr
Journal:  Br J Psychiatry       Date:  1972-08       Impact factor: 9.319

5.  Addiction to diazepam.

Authors:  B M Maletzky; J Klotter
Journal:  Int J Addict       Date:  1976

6.  Mianserin hydrochloride: a novel antidepressant.

Authors:  A Coppen; R Gupta; S Montgomery; K Ghose; J Bailey; B Burns; J J de Ridder
Journal:  Br J Psychiatry       Date:  1976-10       Impact factor: 9.319

7.  Mianserin in the treatment of depression in general practice.

Authors:  J E Murphy; J F Donald; A L Molla
Journal:  Practitioner       Date:  1976-07

8.  Depressive illness in a general practice. A demographic study and a controlled trial of imipramine.

Authors:  A M Porter
Journal:  Br Med J       Date:  1970-03-28

9.  Anxiety and sleep after fosazepam.

Authors:  S Allen; I Oswald
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

  9 in total
  10 in total

1.  The effects of some putative antidepressant agents on the schedule-controlled behavior of the pigeon.

Authors:  R J Lamb; D E McMillan
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  The yohimbine-induced anticonflict effect in the rat, Part I. Involvement of noradrenergic, serotonergic and endozepinergic(?) mechanisms.

Authors:  A Söderpalm; O Blomqvist; B Söderpalm
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 3.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

4.  5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model.

Authors:  G A Kennett
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 5.  Low dosage tricyclic antidepressants for depression.

Authors:  T Furukawa; H McGuire; C Barbui
Journal:  Cochrane Database Syst Rev       Date:  2003

6.  Mianserin and doxepin in the treatment of outpatient depression with anxiety.

Authors:  M C Khan; E H Bennie; S M Stulemeijer; M A Ravens
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

7.  Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety.

Authors:  G A Kennett; K Pittaway; T P Blackburn
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

8.  In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.

Authors:  G A Kennett; M D Wood; A Glen; S Grewal; I Forbes; A Gadre; T P Blackburn
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

9.  Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.

Authors:  M Davis; J V Cassella; J H Kehne
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Drug treatment of psychiatric patients in general practice.

Authors:  P Tyrer
Journal:  Br Med J       Date:  1978-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.